We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Quickfire roundup of the pet industry – what investors need to know

HL’s Lead Equity Analyst, Sophie Lund-Yates, shares her quickfire thoughts on shares with exposure to the pet industry.

Important notes

This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.

The pet industry boomed over lockdown. Millions of us in the UK alone got a pet. Now as with most consumer trends, certain companies got a boost from this change.

But a surface level spike in demand doesn’t mean all companies with exposure to the pet sector are on equal footing. It’s important to understand where these companies stand now. We think there’s ongoing opportunity, but there are a few things to keep in mind.

This article isn’t personal advice. If you’re unsure if an investment is right for you, seek advice. All investments can go down as well as up in value, and you could get back less than you invest.

Investing in individual companies isn’t right for everyone – it’s higher risk than investing in funds as your investment is dependent on the fate of that company. If a company fails, you risk losing your whole investment. You should make sure you understand the companies you’re investing in, their specific risks, and make sure any shares you own are held as part of a diversified portfolio.

Join the 190,000 people already signed up and get our expert investment research direct to your inbox every week. Sign up now.

Pets at Home

This one doesn’t need too much introduction, it’s the pet store chain with almost 460 shops throughout the UK. As you can imagine, the pet boom during the pandemic meant Pets did very well. Even as things were uncertain, all those new puppies and kittens needed their supplies. As these animals grow, they become long-term sources of repeating revenue.

What’s very interesting with Pets at Home is its hybrid approach. 41% of omnichannel revenue involves input from a store colleague, so think of that in terms of things like click & collect or ordering something in store. 57% of the group’s shops also have a vet practice or grooming salon – offering services in this way is a great way to encourage repeat custom and massively increases cross-selling. That’s also true of Pets at Home’s VIP club, with over seven million members, its users are more likely to shop across more than one of the group’s channels.

I certainly can’t knock momentum but there are some things it’s prudent to mention.

The valuation shows the market has high hopes for the group, but that does mean there’s more pressure to perform. Keeping up with the market’s expectations is a tough ask at the moment. Pet spending is more resilient than other forms of spend – we’re going to keep feeding our dogs no matter what happens, but customers are more likely to rein in spending on accessories and extras. I think it's likely Pets at Home’s margins are going to come under some pressure.

Pets at Home share price, charts and research

Register for updates on Pets at Home

CVS Group

From a pet superstore to a vet group. CVS Group has over 500 veterinary branches across the UK, Ireland and the Netherlands, plus a handful of diagnostic laboratories and pet crematoria. They're supported by the growing Animed online veterinary pharmacy. As we shift to a more digital world there's reason to think this division will only build scale and become more profitable. Offering services across the broad spectrum of pet needs helps CVS capture as much revenue from owners as possible.

That also feeds into another point, similar to Pets at Home, which is that cats and dogs go to the vets more than once in their life. On a business level that equates to reliable revenue, especially as all the lockdown animals age, which is a morbid way to look at things but true nonetheless.

As is also the case with Pets at Home, CVS Group’s valuation is anticipating high growth levels. But what I would say is this has come down a lot from the very frothy days of a few months ago. That means there’s more breathing room from the market’s perspective than there has been, but at 19.5, the price-to-earnings ratio still suggests the market has high hopes.

CVS share price, charts and research

Register for updates on CVS

Nestle

Nestle’s known for making KitKats but the reality is, Nestle is also responsible for a wide range of brands including Purina Petcare, whose products saw revenue rise by double digits last year. What’s interesting, and a potential growth lever of the longer-term, is the rising success of the group’s science-based brands and vet products.

As the world becomes more pet-obsessed and all these new owners continue to humanise their furry friends, spending more on specialist food is a trend that should progress. Of course in the immediate term with inflation biting this might not play out fully.

The larger contributor to Nestle’s organic growth tends to be its coffee products, it looks after Starbucks at-home drinks too. But as an option that offers exposure to the booming pet trade, while offering other goods, Nestle is an interesting one.

Nestle share price, charts and research

Register for updates on Nestle

Content for this article comes from a recent episode of HL’s Switch Your Money On Podcast. For further insights to sector and market news you can listen to all available episodes now.

Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Past performance is not a guide to the future. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.

Share insight: our weekly email

Sign up to receive weekly shares content from HL.

Please correct the following errors before you continue:

    Existing client? Please log in to your account to automatically fill in the details below.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Loading

    Your postcode ends:

    Not your postcode? Enter your full address.

    Loading

    Hargreaves Lansdown PLC group companies will usually send you further information by post and/or email about our products and services. If you would prefer not to receive this, please do let us know. We will not sell or trade your personal data.

    What did you think of this article?

    Important notes

    This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.

    Editor's choice – our weekly email

    Sign up to receive the week's top investment stories from Hargreaves Lansdown. Including:

    • Latest comment on economies and markets
    • Expert investment research
    • Financial planning tips
    Sign up

    Related articles

    Category: Markets

    Next week on the stock market

    What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.

    Matt Britzman

    12 Aug 2022 4 min read

    Category: Shares

    Earnings season roundup – the key takeaways for investors

    With another earnings season coming to an end, here are some of the key takeaways for investors.

    Matt Britzman and Sophie Lund-Yates

    11 Aug 2022 6 min read

    Category: Shares

    Investing for dividends – what you need to know

    Investing for dividends is one way to make money from shares. But there are a few things to look out for before snapping up a dividend stock.

    Matt Britzman

    10 Aug 2022 6 min read

    Category: Markets

    Next week on the stock market

    What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.

    Matt Britzman

    05 Aug 2022 5 min read